For Industry
Section: For Industry
Technology commercialization opportunities: below is a list of technologies available for commercial licensing. Click on the category to see a list of inventions related to this category or click on the invention title to see a full description of the licensing opportunity.
For more information about a particular technology, please contact the Case Manager listed in the description or the Office Executive Assistant at (202) 687-7424.
Cancer Therapeutics
- ALK as the Therapeutic Target for the Treatment of Proliferative, Vascular and Neurological Disorders Induced by Pleiotrophin
- Anti-Pleiotrophin Neutralizing Antibodies for the Treatment of Cancer
- Coactivators in the Diagnosis and Treatment of Breast Cancer
- Histone Deacetylase Inhibitors
- Hyaluronic Acid (HA) Conjugation of Anti-Cancer Drugs Increases Their Delivery and Efficacy
- Methods and Composition for the Inhibition of Stat5 in Primary and Advanced Prostate Cancer Cells
- Novel Compounds for Cancer Therapy via the Induction of RASSF1A
- Small Molecular Weight Myc-max Inhibitors
- Targeting of EWS-FLI1 and RHA Interaction as Anti-Tumor Therapy
- The Radiosensitization of Cells Using the P56 Subunit of NF-ΚB
- Voltage Gated Sodium Channel Blockers as Treatment for Prostate Cancer
Neurodegenerative Therapeutics
- 10-Substituted Cytisine Derivatives and Methods of Use Thereof
- ALK as the Therapeutic Target for the Treatment of Proliferative, Vascular and Neurological Disorders Induced by Pleiotrophin
- Alpha-Synuclein Mediated Hyperphosphorylation of Tau in the Genesis of Neurodegenerative Diseases
- Bicyclic Metabotropic Glutamate Receptor Ligands
- Deglycosylated Anti-amyloid Beta Antibodies
- Histone Deacetylase Inhibitors
- Ligands for Metabotropic Glutamate Receptors and Inhibitors of NAALADase
- Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them
- Monomeric and Dimeric Heterocycles for Treating Cocaine Abuse
- Novel Bi- and Tri-Cyclic Aza Compounds and Their Uses
- Novel Tropane Analogs
- Therapeutic Targets for Traumatic Brain Injury
Diagnostics
- A Fast and Easy to Use Diagnostic Technology for Detecting Disease Markers for Cancer and Infection
- A Fast Quantitative Mass Spectrometric Analysis for 1,25-dihydroxyvitamin D3
- ALK as the Therapeutic Target for the Treatment of Proliferative, Vascular and Neurological Disorders Induced by Pleiotrophin
- Anti-Pleiotrophin Neutralizing Antibodies for the Treatment of Cancer
- Biomarkers for Diagnosis and Prognosis of Cervical Cancer
- Biomarkers for Predicting Cardiovascular Risk
- Detection of Hepatocellular Carcinoma Using Analysis of Protein-Associated Glycans
- Methods and Composition for the Inhibition of Stat5 in Primary and Advanced Prostate Cancer Cells
- Sequence-Specific Detection of Nucleotide Sequences for Rapid Detection of Pathogens
- Ultrahigh Density Tissue Microarrays
Viruses, Chronic & Infectious Diseases
- A Fast and Easy to Use Diagnostic Technology for Detecting Disease Markers for Cancer and Infection
- Low Cost Drugs for Treating Patients Suffering from Drug Resistant Malaria
- New Drug Treatments for Flavivirus Infections Such as West Nile and Dengue
- New Flavivirus Inhibitors for Treating Infections Such as West Nile and Dengue
- Novel Anti-Fungal Drugs Against Infections Caused by Candida albicans
- Sequence-Specific Detection of Nucleotide Sequences for Rapid Detection of Pathogens
- Small Molecule Therapeutics for Treating Hepatitis C (HCV)
- Therapeutics for Giardia Lamblia Infections
Respiratory Diseases
- Isotype-Specific Retinoic Acid Receptor (RARβ) Antagonists for the Treatment and Prevention of Lung Disease
- Isotype-Specific Retinoic Acid Receptor (RARγ) agonists for the Treatment and Prevention of Lung Disease
- Treatment of Age-Related Lung Abnormalities Using Estrogen and/or Retinoids
- Treatment of Pulmonary Disorders with Retinoic Acid or Other Retinoids by Inducing Formation of Gas-Exchange Units (Alveoli)
Cardiovascular Diseases
- ALK as the Therapeutic Target for the Treatment of Proliferative, Vascular and Neurological Disorders Induced by Pleiotrophin
- Biomarkers for Predicting Cardiovascular Risk
Research Tools
- ALK as the Therapeutic Target for the Treatment of Proliferative, Vascular and Neurological Disorders Induced by Pleiotrophin
- Anti-Pleiotrophin Neutralizing Antibodies for the Treatment of Cancer
- B-Raf Gene-Targeted Human Cancer Cells for Identification and Testing of Novel Anticancer Drugs
- K-Ras Gene-Targeted Human Cancer Cells for Identification and Testing of Novel Anticancer Drugs
- Oncogenic Beta-Catenin Targeted Human Cancer Cells for Identification and Testing of Novel Anticancer Drugs
- PTEN-deleted Human Cell Lines for Detection of Anticancer Compounds
- Sequence-Specific Detection of Nucleotide Sequences for Rapid Detection of Pathogens
Medical & Research Devices
- Immobilization of Membrane Receptor on HPLC
- Intermaxillary Fixation Device
Bioinformatics
- Automated Forensic Document Fingerprinting
- Database of Related Protein Sequences
- iPro Class Integrated Protein Knowledgebase
Chemistry
- Novel Copper Catalysts for C-H Bond Amination and Olefin Aziridination
- Reversible Room-Temperature Ionic Liquids
- Stereoselective Sensors for Amino Acids, Amines, Amine Alcohols and Carboxylic Acids: Chiral 1,8-Diarylnaphthalenes, Methods of Production and Use
- Synthesis, Structure and Use of Bisoxazolidines for Asymmetric Catalysis and Synthesis
Physics, Optics and Electronic Devices
- A MEMs Based Ferrofludic Deformable Mirror for Optical Imaging and Projection
Other Disorders
- Therapy for Lipomodeling Via Modulation of Neuropeptide Y Receptor
- Treatment of Genetic Skin Disorders with Inhibitors
Quick Links
Latest Technologies
OTC News
Announcement: Oct. 19, 2009 10:06 AM
Thank you for Attending the Socially Responsible Licensing Workshop on October 6
Thank you for Attending the Socially Responsible Licensing Workshop on October 6
